Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Clinical Neurology,Neurology
Reference113 articles.
1. Immunological aspects of approved MS therapeutics;Rommer;Front Immunol,2019
2. Monitoring, switching stopping multiple sclerosis disease-modifying therapies;Gross;Continuum (Minneap Minn),2019
3. Multiple sclerosis in the elderly patient;Awad;Drugs Aging,2010
4. Multidrug use among patients with multiple sclerosis: a cross-sectional study of associations to clinicodemographic factors;Frahm;Sci Rep,2019
5. Polypharmacy among patients with multiple sclerosis: a qualitative systematic review;Frahm;Expert Opin Drug Saf,2020
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis;Scientific Reports;2024-05-28
2. Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry;Therapeutic Advances in Neurological Disorders;2024-01
3. Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis;Pharmaceutics;2023-12-19
4. Vaccination frequency in people newly diagnosed with multiple sclerosis;Multiple Sclerosis Journal;2023-10-13
5. Skin Complications Associated with Interferon-β Treatment in Patients with Multiple Sclerosis, Tehran in 2021 - 2;Journal of Skin and Stem Cell;2023-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3